分析了中国创新医药学学科建设的必要性、存在的主要问题和可借鉴的国外经验，提出了加快推动中国创新医药学学科建设的思考与建议。呼吁凝聚全行业、全社会力量，共同创造利于中国创新医药学人才培养和发展的体系建立，为中国医药创新化发展及全球化发展提供人才保障。
Thoughts and suggestions on accelerating the construction of innovative pharmaceutical medicine discipline in China were put forward by systematically analyzing the necessity of the discipline in China, the main existing problems, and the foreign experiences. This paper also called for gathering the strength of the whole industry and society to create a system conducive to the cultivation and development of talents in the innovative pharmaceutical medicine in China, so as to provide talent resources for innovation and globalization of pharmaceutical medicine development.
[1] Li G, Liu Y, Hu H, et al. Evolution of innovative drug R&D in China[J]. Nature Reviews Drug Discovery, 2022, 21(8): 553-557.
[2] Huang H, Wu D, Miao H, et al. Accelerating the integration of China into the global development of innovative anticancer drugs[J]. The Lancet Oncology, 2022, 23(11): 515-520.
[3] Informa Pharma Intelligence. 中国临床试验格局白皮书[R/OL]. (2023-09) [2023-09-13]. https://pages.pharmaintelligence.informa.com/mandarin-china-landscape.
[4] Citeline. 2023 年医药研发年度回顾[R/OL]. (2023-07)[2023-09-13]. https://euamth. com/Uploads/images/2023/07/06/1688620177_news2_file.
[5] 刘玉秀 . 临床研究的认识观和方法学[J]. 医学研究生学报, 2022, 35(2): 113-117.
[6] Ni J, Zhao J, Ung C O, et al. Obstacles and opportunities in Chinese pharmaceutical innovation[J]. Global Health, 2017, 13(1): 21.
[7] IFAPP. Our history[EB/OL]. [2023-09-13]. https://ifapp.org/about/history.
[8] Kerpel-Fronius S, Rosenkranz B, Allen E, et al. Education and training for medicines development, regulation, and clinical research in emerging countries[J]. Front Pharmacol, 2015, 14(6): 80.
[9] Stonier P D, Silva H, Boyd A, et al. Evolution of the development of core competencies in pharmaceutical medicine and their potential use in education and training[J]. Front Pharmacol, 2020, 19(11): 282.
[10] Peter S, Honorio S, Herman L. Pharmaceutical medicine: History, global status, evolution and development[J]. International Journal of Pharmaceutical Medicine, 2007, 21(4): 253-262.
[11] Criscuolo D. Postgraduate courses in pharmaceutical medicine in Italy[J]. Frontiers of Medicine, 2017, 4: 79.
[12] 王安心, 夏雪, 朱金巧, 等 . 制药医学发展概况及学科建设展望[J]. 首都医科大学学报, 2023, 44(1): 5.
[13] Silva H, Stonier P, Buhler F, et al. Core competencies for pharmaceutical physicians and drug development scientists[J]. Front Pharmacol, 2013, 4: 105.
[14] Imamura K, Criscuolo D, Jurczynska A, et al. International perception of competence, education, and training needs among biomedical professionals involved in medicines development[J]. Front Pharmacol, 2019, 10: 188.
[15] Custers E, Cate O T. The history of medical education in Europe and the United States, with respect to time and proficiency[J]. Academic Medicine, 2018, 93(3): 49-54.
[16] FPM. About[EB/OL]. [2023-09-13]. https://www.fpm.org.uk/about.
[17] 赵一鸣, 曾琳, 李楠 . 临床研究的四个基本特征[J]. 中华医学杂志, 2012, 36: 2521-2523.
[18] Areephanthu C J, Bole R, Stratton T, et al. Impact of professional student mentored research fellowship on medical education and academic medicine career path[J]. Clinical and Translational Science, 2015, 8(5): 479-83.
[19] 王莉, 张典, 史传道, 等 . 医学院校临床研究课程现状与设置策略[J]. 癌症, 2023, 42(2): 4.
[20] 代倩倩, 王燕平, 商洪才, 等 . 从循证医学与转化医学谈中医药临床研究发展[J]. 生物医学转化, 2022, 3: 3.
[21] 冯铁男, 刘怡婷, 缪鑫, 等 . 中美关于临床医师临床研究方法学素养培训的比较研究[J]. 中华医学教育探索杂志, 2022, 1: 1-5.
[22] 花琳琳, 冯宇, 林粤婷, 等 . 高校附属医院医务工作者临床研究培训需求及课程设置分析[J]. 河南医学研究, 2021, 30(16): 3.
